Clinical Trial Update: Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oritavancin to vancomycin for acute bacterial skin and skin structure infections completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abscess
• Bacterial Skin and Skin Structure Infection
• Cellulitis
• Wound Infection

Drugs mentioned

• Oritavancin (oritavancin)
• Vancomycin (vancomycin)

Snippet

Sponsor: Melinta Therapeutics, Inc. | Conditions: Wound Infection, Abscess | Phase 3 | Status: COMPLETED | Results posted: 2022-08-01